Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
ZHONGCHAO Aktie jetzt für 0€ handeln | |||||
25.04. | Zhongchao Inc. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
20.12.24 | Zhongchao Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
13.12.24 | Zhongchao Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
20.11.24 | Zhongchao Inc. - 6-K, Report of foreign issuer | - | SEC Filings | ||
07.08.24 | Pre-market Movers: Scorpius Holdings, G1 Therapeutics, Talis Biomedical, Zhongchao, Emergent BioSolutions | 838 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.40 A.M. ET).In the Green G1 Therapeutics, Inc. (GTHX) is up over 66% at $7.08.
Zhongchao... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
UNITEDHEALTH | 262,00 | -5,00 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
FRESENIUS | 42,180 | +0,98 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
INCANNEX HEALTHCARE | 0,671 | 0,00 % | Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On? | ||
BRIGHTSPRING HEALTH SERVICES | 23,480 | 0,00 % | IPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point | ||
ALIGNMENT HEALTHCARE | 14,910 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 48,060 | -0,19 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
NUTEX HEALTH | 158,61 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
GENEDX | 59,51 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
FRESENIUS MEDICAL CARE | 50,60 | +1,20 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
HIMS & HERS HEALTH | 52,92 | -3,36 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
PROCEPT BIOROBOTICS | 54,75 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
BASEL MEDICAL GROUP | 1,640 | 0,00 % | Basel Medical Group Ltd: Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia | Singapore, April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare... ► Artikel lesen | |
AVEANNA HEALTHCARE | 5,820 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook | First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared... ► Artikel lesen | |
PROGYNY | 21,860 | 0,00 % | Progyny erweitert Medizinischen Beirat um zwei renommierte Ärztinnen | ||
LIFEMD | 9,560 | 0,00 % | LifeMD, Inc.: LifeMD Reports Fourth Quarter 2024 Results | Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 millionTelehealth adjusted EBITDA increased 396% to $5.9 millionFull-year... ► Artikel lesen |